Mantle cell lymphoma (MCL) is a mostly incurable malignancy arising from naive B cells
(NBCs) in the mantle zone of lymph nodes. We analyzed genomewide methylation in MCL …

Background Mantle cell lymphoma (MCL) is genetically characterized by the t (11; 14)(q13;
q32) translocation and a high number of secondary chromosomal alterations. The …

Mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) are mature CD5+ B‐
cell malignancies with different biological/clinical characteristics. We recently reported an …

We analyzed the in silico purified DNA methylation signatures of 82 mantle cell lymphomas
(MCL) in comparison with cell subpopulations spanning the entire B cell lineage. We …

Mantle cell lymphoma (MCL) is a mature B-cell neoplasm initially driven by CCND1
rearrangement with 2 molecular subtypes, conventional MCL (cMCL) and leukemic non …

Mantle cell lymphoma (MCL) is a phenotypically and genetically heterogeneous malignancy
in which the genetic alterations determining clinical indications are not fully understood …

Objective: Mantle cell lymphoma (MCL) is a rare subtype of non-Hodgkin lymphoma (NHL)
with high heterogeneity and a high recurrence rate. How heterogenous cell populations …

Mantle cell lymphoma (MCL) is an uncommon B-cell non-Hodgkin lymphoma (NHL) that is
incurable with standard therapies. The genetic drivers of this cancer have not been firmly …

To gain insight into the molecular pathogenesis of patients with mantle cell lymphoma
(MCL), next-generation whole-exome sequencing of 16 MCL patients was performed. We …

Mantle cell lymphoma (MCL) is a well-defined lymphoid malignancy characterized by a
rapid clinical evolution and poor response to current therapeutic protocols. The hallmark …